Comparative Study on Chiral Separation of Afoxolaner on Polysaccharide-Based Chiral Stationary Phases by Supercritical Fluid Chromatography and High-Performance Liquid Chromatography
- PMID: 41159220
- DOI: 10.1002/jssc.70310
Comparative Study on Chiral Separation of Afoxolaner on Polysaccharide-Based Chiral Stationary Phases by Supercritical Fluid Chromatography and High-Performance Liquid Chromatography
Abstract
Supercritical fluid chromatography (SFC)-based chiral separation has been considered as one of the green, highly efficient, and precise methods for the resolution of new chiral pharmaceuticals. Herein, a comparative study of chiral separation of afoxolaner on polysaccharide-based chiral stationary phases (CSPs) by SFC and high-performance liquid chromatography (HPLC) has been conducted. First, effects of chromatographic conditions on chiral separation of afoxolaner by SFC, including CSPs, modifier types and ratios, flow rate, column temperature, and back pressure, have been discussed in detail. Cellulose tris(4-methylbenzoate)-coated CSP demonstrated the best separation performance for afoxolaner by SFC with the resolution of 2.37 among five CSPs. Afoxolaner enantiomers were eluted at 3.53 min and 4.54 min under the optimized SFC conditions, respectively, and the total analysis time was less than 6 min, much shorter than that by HPLC. Subsequently, molecular docking studies revealed that hydrogen bonds and halogen bonds formed by afoxolaner and CSPs dominated the selective interaction for the separation of afoxolaner. Additionally, hydrophobic effects and π-π stacks between afoxolaner and chiral selectors enhanced the resolution of afoxolaner. Moreover, quantitative determination results of afoxolaner by SFC showed good linearity relationships (R2 > 0.999) between concentration of enantiomers and the corresponding chromatographic peak area in the range from 0.025 to 0.800 mg/mL, and the limit of quantification of enantiomers was 0.025 mg/mL. In brief, SFC separation would offer a green alternative to overcome potential technical bottlenecks in the resolution of new chiral pharmaceuticals.
Keywords: afoxolaner, chiral separation; comparative study, quantitative determinations, supercritical fluid chromatography (SFC).
© 2025 Wiley‐VCH GmbH.
References
-
- L. A. Nguyen, H. He, and P. H. Chuong, “Chiral Drugs: An Overview,” International Journal of Biomedical Sciences 2, no. 2 (2006): 85–100.
-
- I. D'acquarica and I. Agranat, “The Quest for Secondary Pharmaceuticals: Drug Pepurposing/Chiral‐switches Combination Strategy,” ACS Pharmacology & Translational Science 6, no. 2 (2023): 201–219, https://doi.org/10.1021/acsptsci.2c00151.
-
- Q. R. Wang, K. S. Li, F. X. Chen, et al., “Enantiomer‐specific Effects of Metamifop on Serum Metabolism in Rats,” Ecotoxicol Environ Safety 285 (2024): 117008, https://doi.org/10.1016/j.ecoenv.2024.117008.
-
- W. Q. Jiang, Z. Y. Zhao, Q. Zhao, et al., “Enantioselective Toxicity of Ibuprofen to Earthworms: Unraveling the Effect and Mechanism on Enhanced Toxicity of S‐ibuprofen Over R‐ibuprofen,” Environmental Science & Technology 59, no. 1 (2024): 756–766, https://doi.org/10.1021/acs.est.4c08655.
-
- D. Begimbetova, A. N. Burska, A. Baltabekova, et al., “The Vitamin C Enantiomers Possess a Comparable Potency in the Induction of Oxidative Stress in Cancer Cells but Differ in Their Toxicity,” International Journal of Molecular Sciences 25, no. 5 (2024): 2531, https://doi.org/10.3390/ijms25052531.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
